UK markets close in 1 hour

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.9500-0.0200 (-0.50%)
As of 10:30AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close3.9700
Open3.9900
Bid3.9400 x 2800
Ask4.0600 x 100
Day's range3.9100 - 4.0300
52-week range3.5300 - 11.3600
Volume315,242
Avg. volume7,372,846
Market cap552.814M
Beta (5Y monthly)1.60
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Insider Monkey

    12 Most Shorted Stocks in 2024

    In this article, we will take a detailed look at the 12 Most Shorted Stocks in 2024. For a quick overview of such stocks, read our article 5 Most Shorted Stocks in 2024. Short-sellers may be annoying for corporations (and Redditors?), but investors usually find themselves thanking these companies for doing the often back-breaking and excruciating research that […]

  • Reuters

    UPDATE 4-Novavax investor Shah Capital pushes for board shakeup

    Novavax shareholder Shah Capital is pushing the vaccine maker to add two of its nominees to the board to help tackle "underperformance" at the company and improve its share price. The hedge fund nominated Suresh Katta, founder and CEO of biotech firm Saama, and Venkat Peri, CEO of Quantiva Health, to Novavax's eight-member board, saying the duo had the experience in setting the company's strategic direction.

  • Zacks

    Will Novavax's (NVAX) Strategic Reshaping Curb Cash Burn?

    To extend its existing cash runway and curb cash burn, Novavax (NVAX) initiates multiple restructuring initiatives that are aimed at lowering operating expenses and enhancing profitability.